JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
Flowserve
FLS
$9.28B
| $6.16M | ﹤0.01% |
136,549
-66,384
| -33% | -$2.9M |
2013 Q2
23 quarters
|
|
|
CRC
2327
DELISTED
California Resources Corporation
CRC
| $6.15M | ﹤0.01% |
239,344
+84,031
| +54% | +$1.82M |
2014 Q4
17 quarters
|
|
2328
CALL
Ecolab
ECL
$78.5B
| $6.13M | ﹤0.01% |
34,700
+10,000
| +40% | +$1.62M |
2018 Q2
3 quarters
|
|
2329
Revvity
RVTY
$17B
| $6.12M | ﹤0.01% |
63,558
-3,203
| -5% | -$288K |
2013 Q2
23 quarters
|
|
2330
CALL
Tencent Music
TME
$12.9B
| $6.12M | ﹤0.01% |
+338,000
| New | +$5.4M |
2019 Q1
0 quarters
|
|
2331
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.27B
| $6.12M | ﹤0.01% |
84,964
-101,175
| -54% | -$7.09M |
2013 Q4
21 quarters
|
|
2332
CALL
Elevance Health
ELV
$86.8B
| $6.11M | ﹤0.01% |
21,300
-22,600
| -51% | -$6.54M |
2017 Q3
6 quarters
|
|
|
CHK
2333
DELISTED
Chesapeake Energy Corporation
CHK
| $6.11M | ﹤0.01% |
9,855
-204
| -2% | -$114K |
2013 Q2
23 quarters
|
|
2334
PUT
Tilray
TLRY
$565M
| $6.11M | ﹤0.01% |
+9,320
| New | +$7.11M |
2019 Q1
0 quarters
|
|
2335
CALL
B&G Foods
BGS
$202M
| $6.11M | ﹤0.01% |
+250,000
| New | +$6.55M |
2019 Q1
0 quarters
|
|
2336
Arcus Biosciences
RCUS
$3.1B
| $6.1M | ﹤0.01% |
488,553
-4,260
| -0.9% | -$46.2K |
2018 Q1
4 quarters
|
|
|
EXPR
2337
DELISTED
Express, Inc.
EXPR
| $6.09M | ﹤0.01% |
71,161
-30,597
| -30% | -$3.08M |
2013 Q2
23 quarters
|
|
|
TDAY
2338
USA Today Co
TDAY
$1.08B
| $6.09M | ﹤0.01% |
579,782
-13,984
| -2% | -$179K |
2017 Q4
5 quarters
|
|
|
DOC
2339
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.08M | ﹤0.01% |
323,498
+6,073
| +2% | +$108K |
2015 Q4
13 quarters
|
|
|
NPTN
2340
DELISTED
NEOPHOTONICS CORP
NPTN
| $6.05M | ﹤0.01% |
962,190
+554,494
| +136% | +$3.88M |
2017 Q4
5 quarters
|
|
2341
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.8B
| $6.05M | ﹤0.01% |
58,107
-7,689
| -12% | -$782K |
2013 Q3
22 quarters
|
|
2342
Hilltop Holdings
HTH
$2.11B
| $6.04M | ﹤0.01% |
331,208
-2,478
| -0.7% | -$46K |
2013 Q2
23 quarters
|
|
2343
PUT
Nu Skin
NUS
$229M
| $6.04M | ﹤0.01% |
+126,300
| New | +$7.65M |
2019 Q1
0 quarters
|
|
2344
CALL
Honeywell
HON
$67.2B
| $6.04M | ﹤0.01% |
40,318
-386,058
| -91% | -$53.9M |
2016 Q2
11 quarters
|
|
|
2345
PUT
Honeywell
HON
$67.2B
| $6.04M | ﹤0.01% |
40,318
-394,885
| -91% | -$55.2M |
2016 Q2
11 quarters
|
|
|
KE
2346
Kimball Electronics
KE
$695M
| $6.02M | ﹤0.01% |
388,489
+24,129
| +7% | +$388K |
2014 Q4
17 quarters
|
|
|
DERM
2347
DELISTED
Dermira, Inc.
DERM
| $6.01M | ﹤0.01% |
443,395
-50,178
| -10% | -$418K |
2015 Q4
13 quarters
|
|
2348
iShares US Aerospace & Defense ETF
ITA
$12.2B
| $6.01M | ﹤0.01% |
60,198
-2,990,108
| -98% | -$292M |
2013 Q3
22 quarters
|
|
2349
Rollins
ROL
$14.6B
| $6M | ﹤0.01% |
216,195
-36,746
| -15% | -$956K |
2015 Q4
13 quarters
|
|
|
CERN
2350
PUT
DELISTED
Cerner Corp
CERN
| $6M | ﹤0.01% |
104,800
-28,900
| -22% | -$1.61M |
2018 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.